Back to search

Article

Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron Variants

2022-03-25

Abstract excerpt

We studied 249,070 patients who were tested for SARS-CoV-2 in the Cleveland Clinic Health System between October 1, 2021 and January 31, 2022. We found that vaccination, especially with recent boosting, was more effective than prior infection and monoclonal antibody therapy against both the delta and omicron variants. Vaccination and prior infection were much less effective against infection with the omicron varia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af97c03b-544b-5c71-a675-cf6f48d1457d
DOI
10.1101/2022.03.24.22272901
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron VariantsDOI 10.1101/2022.03.24.22272901
Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021Semantic proximity
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral LoadsSemantic proximity
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regressionSemantic proximity
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concernSemantic proximity
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity
Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infectionSemantic proximity
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational StudySemantic proximity
COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with CancerSemantic proximity
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, EnglandSemantic proximity
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysisSemantic proximity
COVID-19 Vaccine Effectiveness and the Evidence on Boosters: A Systematic Review (with Partial Evidence on the Omicron Variant)Semantic proximity
The potential impact of Omicron and future variants of concern on SARS-CoV-2 transmission dynamics and public health burden: a modelling studySemantic proximity
Select a neighboring publication to make it the new centre.